Qvanteq Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

Qvanteq General Information

Description

Developer of a thrombogenicity screening capacity technology designed to screen materials used for medical devices with respect to their thrombus formation capacity. The company's platform uses a coating-free surface technology to be applied onto the coronary stent or Nitinol-based peripheral stents, which shows endothelialization and thrombogenicity properties, enabling patients to address the effects of coronary artery stents and reduce thrombus formation and fast healing.

Contact Information

Website
www.qvanteq.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Technoparkstrasse 1
  • CH-8005 Zurich
  • Switzerland
+41 044
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Healthcare Services
Therapeutic Devices
Vertical(s)
Digital Health, HealthTech
Corporate Office
  • Technoparkstrasse 1
  • CH-8005 Zurich
  • Switzerland
+41 044

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Qvanteq Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 30-Oct-2017 Completed Generating Revenue
5. Grant 30-Jul-2016 Completed Generating Revenue
4. Early Stage VC (Series B) 12-Feb-2013 Completed Generating Revenue
3. Seed Round 27-Apr-2010 Completed Generating Revenue
2. Accelerator/Incubator 09-Aug-2009 $9.3K $9.3K Completed Startup
1. University Spin-Out 01-Jan-2009 Completed Startup
To view Qvanteq’s complete valuation and funding history, request access »

Qvanteq Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
To view Qvanteq’s complete cap table history, request access »

Qvanteq Patents

  • 40

    Total Documents Applications and Grants

  • Total Patents Families

  • 19

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Qvanteq Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3941544-A1 Medical device and process of preparing a medical device Pending 19-Mar-2019
US-20220168467-A1 Medical device and process of preparing a medical device Inactive 19-Mar-2019
EP-3840788-A1 Vascular device and method for manufacturing a vascular device Pending 24-Aug-2018
US-20210338897-A1 Vascular device and method for manufacturing a vascular device Pending 24-Aug-2018
JP-2024122982-A Vascular device and method for manufacturing vascular device Pending 24-Aug-2018 A61L27/54
To view Qvanteq’s complete patent history, request access »

Qvanteq Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Qvanteq Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mende Family Office Family Office Minority
Startup Invest Venture Capital Minority
Verve Ventures Venture Capital Minority
Venture Kick Accelerator/Incubator Minority
ETH Zurich University
To view Qvanteq’s complete investors history, request access »

Ready to get started?

Request a free trial

Qvanteq FAQs

  • When was Qvanteq founded?

    Qvanteq was founded in 2009.

  • Where is Qvanteq headquartered?

    Qvanteq is headquartered in Zurich, Switzerland.

  • What is the size of Qvanteq?

    Qvanteq has 4 total employees.

  • What industry is Qvanteq in?

    Qvanteq’s primary industry is Biotechnology.

  • Is Qvanteq a private or public company?

    Qvanteq is a Private company.

  • What is Qvanteq’s current revenue?

    The current revenue for Qvanteq is .

  • How much funding has Qvanteq raised over time?

    Qvanteq has raised $5.15M.

  • Who are Qvanteq’s investors?

    Mende Family Office, Startup Invest, Verve Ventures, Venture Kick, and ETH Zurich have invested in Qvanteq.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »